Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 35.38 | -41.82 |
| PEG Ratio (TTM) | -1.27 | 1.90 |
| P/S Ratio (TTM) | 0.87 | 2.16 |
| P/B Ratio (TTM) | 0.56 | 0.46 |
| P/FCF Ratio (TTM) | -11.34 | 30.56 |
| Price to 5YR AVG Earnings Ratio | -41.25 | -71.77 |
| Price to 5YR AVG FCF Ratio | 19.48 | 9.81 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.29% | 1.90% |
| ROE (TTM) | 1.59% | 2.98% |
| Net Profit Margin (TTM) | 2.45% | 3.93% |
| ROIC 5YR AVG | -0.26% | -0.31% |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -69.27% | 143.32% | 35.53% |
| Revenue | 309.54% | 24.52% | 11.32% |
| Net Income | -71.35% | 153.22% | 35.54% |
| Cash Flow | 2,225.08% | 30.41% | 1,023.13% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 5.32 | 1.05 |
| Quick Ratio (TTM) | 2.73 | 0.73 |
| D/E Ratio (TTM) | N/A | 0.91 |
| Interest Coverage (TTM) | N/A | 4.98 |
| Piotroski F-Score | 3 | 5 |
| Altman Z-Score | 1.27 | 1.92 |
| LTL to 5YR AVG FCF | 1.48 | -0.48 |
| Shares Outstanding Growth 5YR AVG | 4.74% | 10.24% |